- Home
- / CABIO Biotech (Wuhan)
CABIO Biotech (Wuhan)
Stock Price
¥20.9
2024-10-29
Market Capitalization
¥3.5 B
2024-10-29
Revenue
¥541.6 M
FY, 2025
CABIO Biotech (Wuhan) Summary
Company Summary
- Overview
- CABIO Biotech (Wuhan) is a biotechnology company that provides nutritional products. It offers human beings and animal nutrition.
- Type
- Public
- Status
- Active
- Founded
- 2004
- HQ
- Wuhan, CN | view all locations
- Website
- http://www.cabio.cn
- Cybersecurity rating
Table of Contents
LocationsView all
1 location detected
Wuhan, Hubei HQ
China
CABIO Biotech (Wuhan) Financials
Summary Financials
- Revenue (Q1, 2026)
- ¥48.0M
- Gross profit (Q1, 2026)
- ¥30.7M
- Net income (Q1, 2026)
- (¥7.2M)
- Cash (Q1, 2026)
- ¥132.2M
- EBIT (Q1, 2026)
- (¥9.1M)
- Enterprise value
- $3.5B
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2026